Questionnaire Administration for Head and Neck Squamous Cell Carcinoma

Led By Ravi Chandra
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must have a histologically confirmed malignancy whereby pursual of radiation therapy has potential curative benefits for the patient
Must not have
Screening 3 weeks
Treatment Varies
Follow Upup to 3 months post-radiation therapy
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is testing whether "smart" body-weight scales can help monitor weight and nutrition in patients with head and neck cancer undergoing radiation therapy.

Eligible Conditions
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Head and Neck Cancers

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Participants have a type of cancer that can potentially be cured with radiation therapy.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months post-radiation therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months post-radiation therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to treatment
Secondary outcome measures
MD Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN) questionnaire scores
Overall pain scores
Weight loss percentage

Side effects data

From 2020 Phase 3 trial • 177 Patients • NCT01817075
Rash maculo-papular
Skin and subcutaneous tissue disorders - Other, specify
Mucositis oral
Skin ulceration
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cohort I ('Smart" scale weighing)Experimental Treatment2 Interventions
Patients weigh themselves daily using the "Smart" scale over 5-8 weeks during standard radiation therapy.
Group II: Cohort 2 (no weighing)Active Control1 Intervention
Patients do not weigh themselves using the "Smart" scale during standard radiation therapy.

Find a site

Who is running the clinical trial?

Oregon Health and Science UniversityOTHER
937 Previous Clinical Trials
6,831,276 Total Patients Enrolled
OHSU Knight Cancer InstituteLead Sponsor
220 Previous Clinical Trials
2,090,043 Total Patients Enrolled
Cambia Health FoundationUNKNOWN
2 Previous Clinical Trials
173 Total Patients Enrolled
Ravi ChandraPrincipal Investigator
OHSU Knight Cancer Institute

Media Library

Questionnaire Administration Clinical Trial Eligibility Overview. Trial Name: NCT05457478 — N/A
Head and Neck Squamous Cell Carcinoma Clinical Trial 2023: Questionnaire Administration Highlights & Side Effects. Trial Name: NCT05457478 — N/A
Questionnaire Administration 2023 Treatment Timeline for Medical Study. Trial Name: NCT05457478 — N/A
Head and Neck Squamous Cell Carcinoma Research Study Groups: Cohort 2 (no weighing), Cohort I ('Smart" scale weighing)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining slots available for participants in this investigation?

"Data hosted on reveal that this medical study is currently inactive, despite being initially posted in September of 2022 and updated as recently as July 11th. Even so, there are 929 other trials actively recruiting patients right now."

Answered by AI
~4 spots leftby Dec 2023